A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a randomized double‐blind, placebo‐controlled, single centre Phase I study. Thirty‐six (36) subjects are planned to be randomised at 1 site across the 2 parts of the study as follows: ‐ Part A (Single Ascending Dose (SAD) in healthy subjects) ‐ Part B (Multiple Ascending Doses (MAD) in healthy subjects)
Epistemonikos ID: 5412703ab664b69f95eaecab7fff0c66b787d421
First added on: May 22, 2024